SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-042462
Filing Date
2024-10-25
Accepted
2024-10-25 08:52:30
Documents
14
Period of Report
2024-10-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43153
  Complete submission text file 0001493152-24-042462.txt   221899

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE shph-20241021.xsd EX-101.SCH 3030
3 XBRL LABEL FILE shph-20241021_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE shph-20241021_pre.xml EX-101.PRE 24175
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3817
Mailing Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879
Business Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879 (240) 403-4212
Shuttle Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001757499 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41488 | Film No.: 241394419
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)